PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $184,000 | -70.5% | 58,463 | -72.8% | 0.00% | – |
| Q2 2020 | $624,000 | +543.3% | 214,559 | +375.7% | 0.00% | – |
| Q3 2019 | $97,000 | -53.6% | 45,103 | -32.3% | 0.00% | – |
| Q2 2019 | $209,000 | +31.4% | 66,664 | +56.4% | 0.00% | – |
| Q1 2019 | $159,000 | +160.7% | 42,635 | +103.8% | 0.00% | – |
| Q4 2018 | $61,000 | -9.0% | 20,917 | -17.8% | 0.00% | – |
| Q3 2018 | $67,000 | -14.1% | 25,434 | -4.6% | 0.00% | – |
| Q1 2018 | $78,000 | -45.1% | 26,652 | -48.7% | 0.00% | – |
| Q4 2017 | $142,000 | +208.7% | 51,972 | +279.1% | 0.00% | – |
| Q1 2016 | $46,000 | -80.7% | 13,709 | -71.1% | 0.00% | -100.0% |
| Q3 2015 | $238,000 | +36.0% | 47,409 | +90.6% | 0.00% | 0.0% |
| Q1 2015 | $175,000 | -23.9% | 24,875 | -16.5% | 0.00% | -50.0% |
| Q4 2014 | $230,000 | -58.4% | 29,804 | -59.7% | 0.00% | -66.7% |
| Q3 2014 | $553,000 | +453.0% | 74,031 | +512.5% | 0.01% | +500.0% |
| Q1 2014 | $100,000 | – | 12,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
| SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
| Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
| Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
| Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
| Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
| RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |